Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir. [electronic resource]
Producer: 20110318Description: 415-21 p. digitalISSN:- 1527-3350
- Adult
- Aged
- Anemia -- chemically induced
- Antiviral Agents -- therapeutic use
- Cohort Studies
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Genotype
- Hemoglobins -- metabolism
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Japan
- Male
- Middle Aged
- Multivariate Analysis
- Oligopeptides -- therapeutic use
- Polyethylene Glycols -- therapeutic use
- Polymorphism, Single Nucleotide -- genetics
- Pyrophosphatases -- genetics
- Recombinant Proteins
- Retrospective Studies
- Ribavirin -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.